Related Experiment Videos
A genetically defined model for human ovarian cancer.
Jinsong Liu1, Gong Yang, Jennifer A Thompson-Lanza
1Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. jliu@mdanderson.org
Cancer Research
|March 5, 2004
Summary
Researchers created a new model for ovarian cancer by transforming human ovarian surface epithelial cells. These cells mimic key features of human ovarian tumors, offering a novel system for studying the disease and potential therapies.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Common disruptions in p53, retinoblastoma (Rb), and RAS pathways, along with human telomerase reverse transcriptase (hTERT) activation, are observed in ovarian cancer.
- The exact roles of these genetic alterations in ovarian cancer development remain unclear.
Purpose of the Study:
- To investigate the role of p53, Rb, and RAS pathways, and hTERT in ovarian cancer development.
- To establish a novel in vitro and in vivo model system for human ovarian cancer.
Main Methods:
- Human ovarian surface epithelial cells were engineered with SV40 early genomic region, hTERT, and oncogenic HRAS or KRAS alleles.
- Phenotypic analysis and gene expression profiling were performed on the modified cells.
- Tumorigenicity was assessed by subcutaneous and peritoneal injection into immunocompromised mice.
Main Results:
- SV40 and hTERT immortalized cells but did not transform them.
- Introduction of oncogenic RAS (HRAS(V12) or KRAS(V12)) led to tumor formation in mice.
- Transformed cells exhibited ovarian cancer characteristics, including specific histology, ascites formation, CA125 expression, and elevated pro-inflammatory cytokines (IL-1beta, IL-6, IL-8) via the nuclear factor-kappaB pathway.
- Antibodies targeting IL-1beta or IL-8 induced apoptosis in transformed cells and ovarian cancer cells.
Conclusions:
- Engineered human ovarian surface epithelial cells with RAS activation provide a robust model system that recapitulates key features of human ovarian cancer.
- This model system facilitates the study of ovarian cancer pathogenesis and the evaluation of therapeutic strategies targeting specific molecular pathways and cytokines.